囊泡单胺转运体抑制剂:当前应用与未来方向
综述阐述囊泡单胺转运体2(VMAT2)抑制剂在运动障碍与神经精神疾病治疗中的关键作用,包括四苯喹嗪、氘代四苯喹嗪和缬苯那嗪对亨廷顿病、迟发性运动障碍和抽动秽语综合征的疗效;细胞色素P450酶家族遗传变异影响其代谢,需个体化给药;结构研究为开发更强效、更选择性的抑制剂提供依据。
要点
- VMAT2抑制剂对亨廷顿病、迟发性运动障碍和抽动秽语综合征等运动障碍有治疗疗效。
- 细胞色素P450酶家族遗传变异影响VMAT2抑制剂代谢,需个体化给药。
- 近期结构研究为开发更强效和选择性的VMAT2抑制剂提供依据。
核心结论
- 利用药物遗传学实现精准医学并探索VMAT2抑制在更广泛治疗背景中的应用,可能革新神经与精神疾病的治疗框架。
研究设计与样本
- 综述,总结过去十年对VMAT2抑制剂的理解进展。
主要发现
- VMAT2负责将5-羟色胺、多巴胺和去甲肾上腺素等神经递质包装入突触囊泡,促进其在突触传递中的释放和再摄取。
- 四苯喹嗪、氘代四苯喹嗪和缬苯那嗪等VMAT2抑制剂通过减少神经递质储存和释放来调节过度突触活动。
- 细胞色素P450酶家族的遗传变异影响VMAT2抑制剂代谢,需个体化给药以优化疗效并减少不良事件。
- 近期研究进一步揭示了VMAT2抑制机制的结构基础,为开发更强效和选择性的抑制剂铺平道路。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Advancements over the past decade in understanding vesicular monoamine transporter 2 (VMAT2) inhibitors highlight their key role in the treatment of movement and neuropsychiatric disorders. VMAT2 is crucial for packaging neurotransmitters such as serotonin, dopamine, and norepinephrine into synaptic vesicles, facilitating their release and reuptake in synaptic transmission. VMAT2 inhibitors, such as tetrabenazine, deutetrabenazine, and valbenazine, show therapeutic efficacy in managing hyperkinetic movement disorders, including Huntington's disease, tardive dyskinesia, and Tourette's syndrome. These inhibitors modulate excessive synaptic activity by reducing neurotransmitter storage and release. Genetic variations, particularly in the cytochrome P450 enzyme family, influence VMAT2 inhibitor metabolism, necessitating personalised dosing to optimise efficacy and minimise adverse events. Recent studies have provided further structural insights into VMAT2 inhibition mechanisms, paving the way for the development of inhibitors with enhanced potency and selectivity. Leveraging pharmacogenetics for precision medicine and exploring VMAT2 inhibition in broader therapeutic contexts could revolutionise treatment frameworks for neurological and psychiatric conditions.
引用
- Rosenthal LS, Farag M, Aziz NA, et al. Vesicular monoamine transport inhibitors: current uses and future directions. Lancet. 2025. PMID: 40783291. doi:10.1016/S0140-6736(25)01072-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。